Drug intelligence / Profile preview

cynarin

Development stage
Preclinical
Lead developer
Hainan Medical College
Modality
Small Molecules
Administration
Oral
01

Overview

Cynarin is a natural polyphenol and a major active constituent derived from the artichoke (*Cynara scolymus*). While traditionally recognized for its antioxidant, anti-inflammatory, and hepatoprotective properties—particularly in the context of bile production and cholesterol management—recent research has identified it as a potential therapeutic for female infertility. Cynarin specifically targets the GTP-binding pocket of the small GTPase RAB24, a protein that is significantly downregulated in the oocytes of advanced-age women. By interacting with RAB24, cynarin regulates mitophagy and maintains mitochondrial quality, which in turn improves oocyte maturation rates and reduces chromosomal aneuploidy in aged models. It is currently being investigated as a pharmacological intervention to improve oocyte quality in women of advanced maternal age.

Brand names
Cynarine 75Cynarine75Cynarine-75
Other names
1,3-dicaffeoylquinic acid1,3-O-dicaffeoylquinic acidCynarine
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)GSK3 (Glycogen synthase kinase 3 beta)CACNA1A (P-type Calcium Channel)Rab family (Rab GTPases)

Beyond the preview

Go deeper on cynarin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cynarin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call